Esperion Therapeutics shares owned by Connor, Clark & Lunn Investment Management
Quarter-by-quarter ownership of Esperion Therapeutics (ESPR) shares owned by Connor, Clark & Lunn Investment Management
from 13F filings
Historical chart of Connor, Clark & Lunn Investment Management investment in Esperion Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Esperion Therapeutics held by Connor, Clark & Lunn Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Esperion Therapeutics by Connor, Clark & Lunn Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $1.1M | 352k | 2.99 |
| 2023-09-30 | $405k | 414k | 0.98 |
| 2023-06-30 | $261k | 188k | 1.39 |
| 2023-03-31 | $381k | 240k | 1.59 |
| 2022-12-31 | $1.8M | 284k | 6.23 |
| 2022-09-30 | $1.0M | 152k | 6.70 |
| 2019-09-30 | $816k | 22k | 36.65 |
| 2019-06-30 | $611k | 13k | 46.51 |
| 2019-03-31 | $1.8M | 44k | 40.16 |
| 2018-12-31 | $1.9M | 42k | 45.99 |
| 2018-09-30 | $1.8M | 42k | 44.37 |
| 2018-06-30 | $2.2M | 57k | 39.20 |
| 2015-03-31 | $762k | 6.5k | 117.23 |
More positions owned by Connor, Clark & Lunn Investment Management
View all positions for Connor, Clark & Lunn Investment Management